Your trusted source for investing success

Tag: stock

Tech Forecast and Promising Tech Stocks To Buy in 2017

Learn about breakthrough technology about to impact lives around the globe. We cover the entire industry in our FREE investor’s report.   Gain Access

Prophecy Acquires Additional Mining Claims Adjacent to Its Gibellini Vanadium Project, Resumes Environmental Work

Prophecy Development (“Prophecy” or the “Company”) (TSX:PCY, OTCPK:PRPCF, Frankfurt:1P2N) is pleased to announce that it has successfully acquired an additional 105 unpatented lode mining claims (the “Additional Claims”) located adjacent to its existing Gibellini project in Eureka County, Nevada, through the arm’s-length acquisition of 1104002 B.C., a privately held company incorporated

AIT Therapeutics Announces $9.82 Million Private Placement

AIT Therapeutics (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with serious lung infections and pulmonary hypertension, today announced that it has completed a private placement with a select group of investors, which, assuming the exercise of the Tranche A portion

BioStem Technologies Applies for Uplisting to the OTCQX Market

BioStem Technologies (OTC PINK: BSEM) a global life sciences corporation, providing innovative technologies with a concentration in Pharmaceuticals and Regenerative Medicine, announced today that it has completed its application to uplist on OTCQX, a higher tier Over The Counter market overseen by OTCMarkets.

As quoted in the press release:
Henry Van Vurst,

BioAmber Receives Notice of Delisting by TSX

BioAmber (OTCP:BIOA) has announced that the Toronto Stock Exchange (TSX) has notified the company that it will suspend the company’s trading of shares of common stock effective February 16 and to delist the company’s securities effective at market close on March 16.

As quoted in the press release:

These measures were taken

Dolly Varden Grants Options

Dolly Varden Silver (TSX.V: DV | U.S.: DOLLF) (the “Company” or “Dolly Varden”) announces that it has granted an aggregate of 1,200,000 incentive stock options to directors, officers, and consultants to purchase up to 1,200,000 common shares in the capital of Dolly Varden.

The incentive stock options have an exercise price of $0.79 per share,

Amicus Therapeutics Prices Underwritten Offering of Common Stock

Amicus Therapeutics (Nasdaq:FOLD) announced the pricing of an underwritten offering of 19,354,839 shares of its common stock at $15.50 per share. The gross proceeds from the offering to Amicus are expected to be $300 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Amicus.

As quoted in the press

Velocity Reports AGM Results

Velocity Reports AGM Results

Velocity Minerals Ltd. (TSXV:VLC) reports the results of its annual general meeting of shareholders held on February 15, 2018 in Vancouver, British Columbia. All the motions presented to the shareholders were approved.

Catalyst Biosciences Announces Closing of Public Offering of Common Stock

Catalyst Biosciences (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications (the Company), today announced the closing of an underwritten public offering of 3,382,352 shares of its common stock, offered at a price of $34.00 per share to the public, which includes the exercise in

Amicus Therapeutics Announces Public Offering of Common Stock

Amicus Therapeutics (Nasdaq:FOLD) announced it has commenced a $250 million underwritten public offering of its common stock. J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC are acting as joint lead book-running managers, Cowen and Leerink Partners LLC are acting as co-book-running managers, and BofA Merrill Lynch is acting

Avid Bioservices Announces Proposed Offering of Common Stock

Avid Bioservices (NASDAQ:CDMO) announced that it has commenced an underwritten public offering of its common stock. Avid Bioservices also intends to grant the underwriter a 30-day option to purchase from it up to an additional 15% of the shares of common stock offered in the public offering to cover over-allotments, if

10+ Gold Stocks to Watch

Expert Insights.
Industry Stats.

Give me my free report!
Enter Your Log In Credentials
This setting should only be used on your home or work computer.


Privacy & Legal Policy

Privacy Policy

Investing News Network

Send this to a friend

I thought you might find this interesting:
5 Top Weekly NASDAQ Tech Stocks: Index on Pace for Best Week in 6 Years